Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
22.40
+2.00 (9.80%)
At close: Jan 22, 2026, 4:00 PM EST
22.84
+0.44 (1.96%)
After-hours: Jan 22, 2026, 6:13 PM EST
Aktis Oncology Market Cap
Aktis Oncology has a market cap or net worth of $1.18 billion as of January 22, 2026.
Market Cap
1.18B
Enterprise Value
942.14M
1-Year Change
n/a
Ranking
Category
Stock Price
22.40
Market Cap Chart
Since the IPO on January 9, 2026, Aktis Oncology's market cap has increased from $945.40M to $1.18B, an increase of 24.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.07B | 8.68% |
| Jan 20, 2026 | 985.84M | -4.96% |
| Jan 16, 2026 | 1.04B | -3.94% |
| Jan 15, 2026 | 1.08B | -1.20% |
| Jan 14, 2026 | 1.09B | -2.53% |
| Jan 13, 2026 | 1.12B | -1.84% |
| Jan 12, 2026 | 1.14B | 20.83% |
| Jan 9, 2026 | 945.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.07B |
| Zenas BioPharma | 1.05B |
| Phathom Pharmaceuticals | 1.05B |
| Theravance Biopharma | 1.03B |
| Compass Therapeutics | 1.03B |
| Nanobiotix | 1.01B |
| ARS Pharmaceuticals | 998.37M |
| Ventyx Biosciences | 994.82M |